Health Secretary Warns Against Using Ozempic for Ideal Body Image
- Wes Streeting highlighted the potential benefits of weight-loss drugs for individuals struggling with obesity.
- He cautioned against using these medications for cosmetic purposes, warning of possible negative impacts on mental health.
- Streeting concluded that responsible use of these drugs is essential to avoid further strain on the NHS and to promote overall health.
In the UK, Health Secretary Wes Streeting expressed concerns regarding the use of weight-loss drugs like Ozempic and Wegovy during an interview on October 14, 2024. He highlighted that while these medications can significantly aid those struggling with obesity, they should not be misused for cosmetic purposes or as a substitute for healthy lifestyle choices. Streeting emphasized the potential risks of increased eating disorders and body dysmorphia if these drugs are widely adopted without proper guidance. He pointed out that obesity is a major health issue, costing the NHS approximately £6.5 billion annually and being the second leading preventable cause of cancer. The health secretary urged that these drugs should complement, not replace, diet and exercise efforts. He also noted the financial implications of drug use on the NHS, stressing the importance of responsible usage to avoid burdening the healthcare system further.